Revenue Summary of ChemoMetec A/S

ChemoMetec A/S's latest annual revenue in 2024 was 407.87 Million DKK , down -8.22% from previous year.
ChemoMetec A/S's latest quarterly revenue in 2024 FY was 407.87 Million DKK , down -8.22% from previous quarter.
ChemoMetec A/S reported a annual revenue of 444.4 Million DKK in annual revenue 2023, up 3.74% from previous year.
ChemoMetec A/S reported a annual revenue of 428.39 Million DKK in annual revenue 2022, up 52.38% from previous year.
ChemoMetec A/S reported a quarterly revenue of 407.87 Million DKK for 2024 FY, down -8.22% from previous quarter.
ChemoMetec A/S reported a quarterly revenue of 99.89 Million DKK for 2024 Q1, down -50.46% from previous quarter.

Annual Revenue Chart of ChemoMetec A/S (2024 - 2004)

Historical Annual Revenue of ChemoMetec A/S (2024 - 2004)

Year	Revenue	Revenue Growth
2024	407.87 Million DKK	-8.22%
2023	444.4 Million DKK	3.74%
2022	428.39 Million DKK	52.38%
2021	281.12 Million DKK	31.31%
2020	214.1 Million DKK	21.99%
2019	175.51 Million DKK	55.75%
2018	112.68 Million DKK	24.75%
2017	90.32 Million DKK	5.98%
2016	85.23 Million DKK	39.18%
2015	61.23 Million DKK	35.4%
2014	45.22 Million DKK	9.26%
2013	41.39 Million DKK	5.6%
2012	39.2 Million DKK	5.29%
2011	37.23 Million DKK	14.18%
2010	32.6 Million DKK	1.73%
2009	32.05 Million DKK	-28.49%
2008	44.82 Million DKK	100.91%
2007	22.31 Million DKK	52.77%
2006	14.6 Million DKK	27.59%
2005	11.44 Million DKK	32.29%
2004	8.65 Million DKK	0.0%

Year	Revenue	Revenue Growth
2024 Q4	104.03 Million DKK	0.0%
2024 FY	407.87 Million DKK	-8.22%
2024 Q1	99.89 Million DKK	-50.46%
2024 Q2	99.89 Million DKK	0.0%
2024 Q3	104.03 Million DKK	4.14%
2023 FY	444.4 Million DKK	3.74%
2023 Q4	201.67 Million DKK	99.93%
2023 Q3	100.87 Million DKK	-58.08%
2023 Q2	240.6 Million DKK	98.31%
2023 Q1	121.32 Million DKK	-44.18%
2022 FY	428.39 Million DKK	52.38%
2022 Q1	104.9 Million DKK	-29.19%
2022 Q2	209.8 Million DKK	100.0%
2022 Q3	109.29 Million DKK	-47.91%
2022 Q4	217.35 Million DKK	98.87%
2021 FY	281.12 Million DKK	31.31%
2021 Q4	148.14 Million DKK	100.0%
2021 Q3	74.07 Million DKK	-44.3%
2021 Q2	132.98 Million DKK	100.0%
2021 Q1	66.49 Million DKK	-39.83%
2020 Q2	103.59 Million DKK	100.0%
2020 Q1	51.79 Million DKK	-44.48%
2020 Q4	110.5 Million DKK	100.0%
2020 Q3	55.25 Million DKK	-46.67%
2020 FY	214.1 Million DKK	21.99%
2019 Q4	93.3 Million DKK	100.0%
2019 Q2	41.1 Million DKK	0.0%
2019 Q1	41.1 Million DKK	39.17%
2019 FY	175.51 Million DKK	55.75%
2019 Q3	46.65 Million DKK	13.49%
2018 Q4	29.53 Million DKK	0.0%
2018 Q2	26.8 Million DKK	0.0%
2018 FY	112.68 Million DKK	24.75%
2018 Q1	26.8 Million DKK	11.85%
2018 Q3	29.53 Million DKK	10.18%
2017 Q3	23.96 Million DKK	13.06%
2017 FY	90.32 Million DKK	5.98%
2017 Q4	23.96 Million DKK	0.0%
2017 Q2	21.19 Million DKK	0.0%
2017 Q1	21.19 Million DKK	-1.09%
2016 FY	85.23 Million DKK	39.18%
2016 Q1	21.18 Million DKK	28.6%
2016 Q2	21.18 Million DKK	0.0%
2016 Q4	21.43 Million DKK	0.0%
2016 Q3	21.43 Million DKK	1.17%
2015 Q4	16.47 Million DKK	0.0%
2015 FY	61.23 Million DKK	35.4%
2015 Q2	14.14 Million DKK	0.0%
2015 Q1	14.14 Million DKK	26.0%
2015 Q3	16.47 Million DKK	16.44%
2014 Q1	11.38 Million DKK	11.52%
2014 Q3	11.22 Million DKK	-1.4%
2014 Q4	11.22 Million DKK	0.0%
2014 FY	45.22 Million DKK	9.26%
2014 Q2	11.38 Million DKK	0.0%
2013 Q2	10.48 Million DKK	0.0%
2013 Q4	10.21 Million DKK	0.0%
2013 Q3	10.21 Million DKK	-2.64%
2013 Q1	10.48 Million DKK	7.01%
2013 FY	41.39 Million DKK	5.6%
2012 Q3	9.8 Million DKK	5.29%
2012 Q4	9.8 Million DKK	0.0%
2012 FY	39.2 Million DKK	5.29%
2012 Q2	9.3 Million DKK	0.0%
2012 Q1	9.3 Million DKK	0.0%
2011 Q1	8.15 Million DKK	0.0%
2011 Q4	9.3 Million DKK	0.0%
2011 Q3	9.3 Million DKK	14.18%
2011 FY	37.23 Million DKK	14.18%
2011 Q2	8.15 Million DKK	0.0%
2010 Q3	8.15 Million DKK	1.73%
2010 Q2	8.01 Million DKK	0.0%
2010 Q4	8.15 Million DKK	0.0%
2010 Q1	8.01 Million DKK	0.0%
2010 FY	32.6 Million DKK	1.73%
2009 Q4	8.01 Million DKK	0.0%
2009 Q2	11.2 Million DKK	0.0%
2009 Q1	11.2 Million DKK	0.0%
2009 FY	32.05 Million DKK	-28.49%
2009 Q3	8.01 Million DKK	-28.49%
2008 FY	44.82 Million DKK	100.91%
2008 Q4	11.2 Million DKK	0.0%
2008 Q3	11.2 Million DKK	100.91%
2008 Q1	5.57 Million DKK	0.0%
2008 Q2	5.57 Million DKK	0.0%
2007 Q4	5.57 Million DKK	0.0%
2007 Q3	5.57 Million DKK	52.77%
2007 Q2	3.65 Million DKK	0.0%
2007 FY	22.31 Million DKK	52.77%
2007 Q1	3.65 Million DKK	0.0%
2006 Q4	3.65 Million DKK	0.0%
2006 Q3	3.65 Million DKK	27.59%
2006 FY	14.6 Million DKK	27.59%
2006 Q1	2.86 Million DKK	0.0%
2006 Q2	2.86 Million DKK	0.0%
2005 FY	11.44 Million DKK	32.29%
2005 Q3	2.86 Million DKK	32.29%
2005 Q1	2.16 Million DKK	0.0%
2005 Q2	2.16 Million DKK	0.0%
2005 Q4	2.86 Million DKK	0.0%
2004 Q4	2.16 Million DKK	0.0%
2004 Q3	2.16 Million DKK	0.0%
2004 FY	8.65 Million DKK	0.0%

Peer Revenue Comparison of ChemoMetec A/S

Name	Revenue	Revenue Difference
Ambu A/S	5.39 Billion DKK	92.434%
Demant A/S	22.44 Billion DKK	98.183%
GN Store Nord A/S	18.12 Billion DKK	97.749%
Scandinavian Medical Solutions A/S	191.19 Million DKK	-113.331%
ViroGates A/S	6.98 Million DKK	-5737.555%

Global Stocks Search

ChemoMetec A/S (CHEMM.CO)

Revenue Summary of ChemoMetec A/S

Annual Revenue Chart of ChemoMetec A/S (2024 - 2004)

Historical Annual Revenue of ChemoMetec A/S (2024 - 2004)

Peer Revenue Comparison of ChemoMetec A/S